Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth A Brooks

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Managed Care (Langhorne, Pa.)|July 11, 2018
Cost-Effectiveness Analysis of Monitoring Fractional Exhaled Nitric Oxide (FeNO) in the Management of AsthmaElizabeth A Brooks, Marc Massanari
Open Access Emergency Medicine : OAEM|November 23, 2018
Potential mortality and cost reduction in adult severe sepsis and septic shock through the use of an innovative fluid delivery deviceElizabeth A Brooks, Mark Piehl
Managed Care (Langhorne, Pa.)|May 8, 2015
Costs and benefits of bundled community-based screening for carotid artery stenosis, peripheral artery disease, and abdominal aortic aneurysmSteven M Weisman, Elizabeth A Brooks
Allergy and Asthma Proceedings|April 12, 2011
Exhaled nitric oxide as a tool in managing and monitoring difficult-to-treat asthmaDon Bukstein, Allan T Luskin, Elizabeth A Brooks
Clinicoeconomics and Outcomes Research : CEOR|May 23, 2019
Cost-effectiveness of fractional exhaled nitric oxide (FeNO) measurement in predicting response to omalizumab in asthmaElizabeth A Brooks, Marc Massanari, Nicola A Hanania, et al.
International Orthopaedics|August 2, 2018
Comparative cost-effectiveness analysis of the subacromial spacer for irreparable and massive rotator cuff tearsAlessandro Castagna, Raffaele Garofalo, Eran Maman, et al.
APL Bioengineering|July 3, 2019
An omentum-inspired 3D PEG hydrogel for identifying ECM-drivers of drug resistant ovarian cancerElizabeth A Brooks, Maria F Gencoglu, Daniel C Corbett, et al.
ACS Biomaterials Science & Engineering|January 9, 2021
Complementary, Semiautomated Methods for Creating Multidimensional PEG-Based BiomaterialsElizabeth A Brooks, Lauren E Jansen, Maria F Gencoglu, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|August 22, 2019
Applicability of drug response metrics for cancer studies using biomaterialsElizabeth A Brooks, Sualyneth Galarza, Maria F Gencoglu, et al.
ACS Biomaterials Science & Engineering|March 13, 2018
Comparative Study of Multicellular Tumor Spheroid Formation Methods and Implications for Drug ScreeningMaria F Gencoglu, Lauren E Barney, Christopher L Hall, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Managed Care (Langhorne, Pa.)|July 11, 2018
Cost-Effectiveness Analysis of Monitoring Fractional Exhaled Nitric Oxide (FeNO) in the Management of AsthmaElizabeth A Brooks, Marc Massanari
Open Access Emergency Medicine : OAEM|November 23, 2018
Potential mortality and cost reduction in adult severe sepsis and septic shock through the use of an innovative fluid delivery deviceElizabeth A Brooks, Mark Piehl
Managed Care (Langhorne, Pa.)|May 8, 2015
Costs and benefits of bundled community-based screening for carotid artery stenosis, peripheral artery disease, and abdominal aortic aneurysmSteven M Weisman, Elizabeth A Brooks
Allergy and Asthma Proceedings|April 12, 2011
Exhaled nitric oxide as a tool in managing and monitoring difficult-to-treat asthmaDon Bukstein, Allan T Luskin, Elizabeth A Brooks
Clinicoeconomics and Outcomes Research : CEOR|May 23, 2019
Cost-effectiveness of fractional exhaled nitric oxide (FeNO) measurement in predicting response to omalizumab in asthmaElizabeth A Brooks, Marc Massanari, Nicola A Hanania, et al.
International Orthopaedics|August 2, 2018
Comparative cost-effectiveness analysis of the subacromial spacer for irreparable and massive rotator cuff tearsAlessandro Castagna, Raffaele Garofalo, Eran Maman, et al.
APL Bioengineering|July 3, 2019
An omentum-inspired 3D PEG hydrogel for identifying ECM-drivers of drug resistant ovarian cancerElizabeth A Brooks, Maria F Gencoglu, Daniel C Corbett, et al.
ACS Biomaterials Science & Engineering|January 9, 2021
Complementary, Semiautomated Methods for Creating Multidimensional PEG-Based BiomaterialsElizabeth A Brooks, Lauren E Jansen, Maria F Gencoglu, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|August 22, 2019
Applicability of drug response metrics for cancer studies using biomaterialsElizabeth A Brooks, Sualyneth Galarza, Maria F Gencoglu, et al.
ACS Biomaterials Science & Engineering|March 13, 2018
Comparative Study of Multicellular Tumor Spheroid Formation Methods and Implications for Drug ScreeningMaria F Gencoglu, Lauren E Barney, Christopher L Hall, et al.
Pageof 2